false --12-31 Q3 0001166708 0001166708 2026-01-01 2026-09-30 0001166708 2026-11-04 0001166708 2026-09-30 0001166708 2025-12-31 0001166708 us-gaap:NonrelatedPartyMember 2026-09-30 0001166708 us-gaap:NonrelatedPartyMember 2025-12-31 0001166708 us-gaap:RelatedPartyMember 2026-09-30 0001166708 us-gaap:RelatedPartyMember 2025-12-31 0001166708 2026-07-01 2026-09-30 0001166708 2025-07-01 2025-09-30 0001166708 2025-01-01 2025-09-30 0001166708 us-gaap:NonrelatedPartyMember 2026-07-01 2026-09-30 0001166708 us-gaap:NonrelatedPartyMember 2025-07-01 2025-09-30 0001166708 us-gaap:NonrelatedPartyMember 2026-01-01 2026-09-30 0001166708 us-gaap:NonrelatedPartyMember 2025-01-01 2025-09-30 0001166708 us-gaap:RelatedPartyMember 2026-07-01 2026-09-30 0001166708 us-gaap:RelatedPartyMember 2025-07-01 2025-09-30 0001166708 us-gaap:RelatedPartyMember 2026-01-01 2026-09-30 0001166708 us-gaap:RelatedPartyMember 2025-01-01 2025-09-30 0001166708 us-gaap:PreferredStockMember 2024-12-31 0001166708 us-gaap:CommonStockMember 2024-12-31 0001166708 BWMG:CommonStockPayableMember 2024-12-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001166708 us-gaap:RetainedEarningsMember 2024-12-31 0001166708 2024-12-31 0001166708 us-gaap:PreferredStockMember 2025-12-31 0001166708 us-gaap:CommonStockMember 2025-12-31 0001166708 BWMG:CommonStockPayableMember 2025-12-31 0001166708 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001166708 us-gaap:RetainedEarningsMember 2025-12-31 0001166708 us-gaap:PreferredStockMember 2025-01-01 2025-09-30 0001166708 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001166708 BWMG:CommonStockPayableMember 2025-01-01 2025-09-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001166708 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001166708 us-gaap:PreferredStockMember 2026-01-01 2026-09-30 0001166708 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001166708 BWMG:CommonStockPayableMember 2026-01-01 2026-09-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-09-30 0001166708 us-gaap:RetainedEarningsMember 2026-01-01 2026-09-30 0001166708 us-gaap:PreferredStockMember 2025-09-30 0001166708 us-gaap:CommonStockMember 2025-09-30 0001166708 BWMG:CommonStockPayableMember 2025-09-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001166708 us-gaap:RetainedEarningsMember 2025-09-30 0001166708 2025-09-30 0001166708 us-gaap:PreferredStockMember 2026-09-30 0001166708 us-gaap:CommonStockMember 2026-09-30 0001166708 BWMG:CommonStockPayableMember 2026-09-30 0001166708 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001166708 us-gaap:RetainedEarningsMember 2026-09-30 0001166708 BWMG:SoleMember 2026-07-01 2026-07-01 0001166708 BWMG:EmployeeMember 2026-07-01 2026-07-01 0001166708 BWMG:SoleMember 2026-07-01 0001166708 BWMG:RobertCarmichaelMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2026-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2025-12-31 0001166708 BWMG:RobertCarmichaelMember 2026-09-30 0001166708 BWMG:RobertCarmichaelMember 2025-12-31 0001166708 BWMG:BrowniesGlobalLogisticsMember us-gaap:RelatedPartyMember 2026-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2026-09-30 0001166708 BWMG:BlakeCarmichaelMember us-gaap:RelatedPartyMember 2026-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:RelatedPartyMember 2025-12-31 0001166708 BWMG:BrowniesGlobalLogisticsMember us-gaap:RelatedPartyMember 2025-12-31 0001166708 BWMG:LicenseAgreementMember 2026-01-01 2026-09-30 0001166708 BWMG:LicenseAgreementMember 2025-01-01 2025-09-30 0001166708 BWMG:LicenseAgreementMember 2026-09-30 0001166708 BWMG:LicenseAgreementMember 2025-12-31 0001166708 BWMG:RobertCarmichaelMember BWMG:PromissoryNoteMember 2022-09-30 0001166708 BWMG:PromissoryNoteMember BWMG:RobertCarmichaelMember 2022-09-29 2022-09-30 0001166708 BWMG:PromissoryNoteMember BWMG:RobertCarmichaelMember 2026-09-30 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-01-18 2023-01-18 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-02-18 2023-02-18 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-01-18 0001166708 BWMG:CharlesHyattMember us-gaap:WarrantMember 2023-02-18 0001166708 BWMG:RobertCarmichaelMember BWMG:BLU3IncMember 2023-09-14 0001166708 BWMG:RobertCarmichaelMember BWMG:BLU3IncMember 2023-09-14 2023-09-14 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteMember 2023-11-14 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteMember 2025-12-31 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteMember 2023-11-13 2023-11-13 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteMember 2023-11-14 2023-11-14 0001166708 BWMG:RobertCarmichaelMember BWMG:PromissoryNoteOneMember 2023-12-23 0001166708 BWMG:RobertCarmichaelMember BWMG:BLU3IncMember 2023-12-23 2023-12-23 0001166708 BWMG:BLU3IncMember 2026-09-30 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteOneMember 2025-02-05 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteOneMember 2025-02-04 2025-02-04 0001166708 BWMG:CharlesHyattMember BWMG:PromissoryNoteOneMember 2025-02-05 2025-02-05 0001166708 2026-06-08 2026-06-08 0001166708 2025-02-05 2025-02-05 0001166708 2023-11-14 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001166708 BWMG:RobertCarmichaelMember us-gaap:CommonStockMember 2025-07-16 2025-07-16 0001166708 BWMG:BlakeCarmichaelMember us-gaap:CommonStockMember 2025-12-09 2025-12-09 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:SummitHoldingVLLCMember 2026-01-01 2026-09-30 0001166708 BWMG:ConvertibleDebentureMember BWMG:TierraVistaPartnersLLCMember 2026-01-01 2026-09-30 0001166708 BWMG:ConvertiblePromissoryNotePayableOneMember 2026-01-01 2026-09-30 0001166708 BWMG:ConvertiblePromissoryNotePayableOneMember 2026-09-30 0001166708 BWMG:ConvertiblePromissoryNotePayableTwoMember 2026-01-01 2026-09-30 0001166708 BWMG:ConvertiblePromissoryNotePayableTwoMember 2026-09-30 0001166708 BWMG:ConvertiblePromissoryNotePayableThreeMember 2026-01-01 2026-09-30 0001166708 BWMG:ConvertiblePromissoryNotePayableThreeMember 2026-09-30 0001166708 BWMG:ConvertiblePromissoryNotePayableFourMember 2026-09-30 0001166708 BWMG:ConvertiblePromissoryNotePayableFourMember 2026-01-01 2026-09-30 0001166708 BWMG:SummitHoldingsVLLCNoteMember us-gaap:ConvertibleDebtSecuritiesMember 2026-09-30 0001166708 BWMG:TierraVistaPartnersLLCNoteMember us-gaap:ConvertibleDebtSecuritiesMember 2026-09-30 0001166708 BWMG:RobertCarmichaelLBINoteMember us-gaap:ConvertibleDebtSecuritiesMember 2026-09-30 0001166708 us-gaap:ConvertibleDebtSecuritiesMember 2026-09-30 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:SummitHoldingVLLCMember 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:SummitHoldingVLLCMember 2021-09-03 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:TierraVistaPartnersLLCMember 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:TierraVistaPartnersLLCMember 2021-09-03 2021-09-03 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:RobertCarmichaelMember 2022-09-30 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:RobertCarmichaelMember 2022-09-30 2022-09-30 0001166708 us-gaap:ConvertibleNotesPayableMember BWMG:RobertCarmichaelMember 2026-09-30 0001166708 BWMG:NavitasTwoThousandTwentyFourBLU3Member 2026-09-30 0001166708 BWMG:NavitasTwoThousandTwentySixBLU3Member 2026-09-30 0001166708 BWMG:NavitasTwoThousandTwentySixBTLMember 2026-09-30 0001166708 BWMG:BankUnitedTwoThousandTwentySixBLU3Member 2026-09-30 0001166708 BWMG:Navitas2024BLU3Member BWMG:InventoryFinanceAgreementMember 2024-02-12 0001166708 BWMG:Navitas2024BLU3Member BWMG:InventoryFinanceAgreementMember 2024-02-12 2024-02-12 0001166708 BWMG:Navitas2024BLU3OneMember BWMG:InventoryFinanceAgreementMember 2026-09-30 0001166708 BWMG:Navitas2024BLU3OneMember BWMG:InventoryFinanceAgreementMember 2025-12-31 0001166708 BWMG:BLU3IncMember BWMG:EquipmentFinanceAgreementMember 2026-06-10 0001166708 BWMG:BLU3IncMember BWMG:EquipmentFinanceAgreementMember 2026-06-10 2026-06-10 0001166708 BWMG:BLU3IncMember BWMG:EquipmentFinanceAgreementMember 2026-09-30 0001166708 BWMG:BrowniesThirdLungMember BWMG:InventoryFinanceAgreementMember 2024-10-04 0001166708 BWMG:BrowniesThirdLungMember BWMG:InventoryFinanceAgreementMember 2026-10-04 2026-10-04 0001166708 BWMG:BrowniesThirdLungMember BWMG:EquipmentFinanceAgreementMember 2026-10-04 2026-10-04 0001166708 BWMG:BrowniesThirdLungMember BWMG:InventoryFinanceAgreementMember 2026-09-30 0001166708 BWMG:BrowniesThirdLungMember BWMG:InventoryFinanceAgreementMember 2025-12-31 0001166708 BWMG:BankUnitedTwoThousandTwentySixBLU3Member BWMG:EquipmentFinanceAgreementMember 2026-03-23 0001166708 BWMG:BankUnitedTwoThousandTwentySixBLU3Member BWMG:EquipmentFinanceAgreementMember 2026-03-23 2026-03-23 0001166708 BWMG:BankUnitedTwoThousandTwentySixBLU3Member BWMG:EquipmentFinanceAgreementMember 2026-09-30 0001166708 us-gaap:PatentsMember 2026-09-30 0001166708 us-gaap:TrademarksMember 2026-09-30 0001166708 us-gaap:CustomerRelationshipsMember 2026-09-30 0001166708 us-gaap:NoncompeteAgreementsMember 2026-09-30 0001166708 BWMG:MrCharlesFHyattMember 2023-01-18 2023-01-18 0001166708 BWMG:MrCharlesFHyattMember 2023-02-18 2023-02-18 0001166708 BWMG:MrCharlesFHyattMember 2023-01-18 0001166708 BWMG:MrCharlesFHyattMember 2023-02-18 0001166708 BWMG:RobertCarmichaelMember 2023-03-31 2023-03-31 0001166708 BWMG:ConvertibleNotesHolderMember 2023-01-01 2023-03-31 0001166708 BWMG:RobertCarmichaelMember 2023-04-01 2023-06-30 0001166708 BWMG:ConvertibleNotesHolderMember 2023-04-01 2023-06-30 0001166708 BWMG:RobertCarmichaelMember 2023-07-01 2023-09-30 0001166708 BWMG:ConvertibleNotesHolderMember 2023-07-01 2023-09-30 0001166708 BWMG:RobertCarmichaelMember 2023-10-01 2023-12-31 0001166708 BWMG:ConvertibleNotesHolderMember 2023-10-01 2023-12-31 0001166708 BWMG:RobertCarmichaelMember 2025-01-01 2025-03-31 0001166708 BWMG:ConvertibleNotesHolderMember 2025-01-01 2025-03-31 0001166708 BWMG:RobertCarmichaelMember 2025-04-01 2025-06-30 0001166708 BWMG:ConvertibleNotesHolderMember 2025-04-01 2025-06-30 0001166708 BWMG:ConvertibleNotesHolderMember 2025-08-15 2025-08-15 0001166708 BWMG:ConvertibleNotesHolderMember 2025-10-01 2025-12-31 0001166708 BWMG:BlakeCarmichaelMember 2025-08-31 2025-08-31 0001166708 BWMG:BlakeCarmichaelMember 2025-09-30 2025-09-30 0001166708 BWMG:ConvertibleNotesHolderMember 2025-07-01 2025-09-30 0001166708 BWMG:BlakeCarmichaelMember 2025-12-31 2025-12-31 0001166708 BWMG:BlakeCarmichaelMember 2026-01-31 2026-01-31 0001166708 BWMG:BlakeCarmichaelMember 2026-02-28 2026-02-28 0001166708 BWMG:BlakeCarmichaelMember 2026-03-31 2026-03-31 0001166708 BWMG:ConvertibleNotesHolderMember 2026-01-01 2026-03-31 0001166708 BWMG:BlakeCarmichaelMember 2026-04-30 2026-04-30 0001166708 BWMG:AllenWhiteMember 2026-05-01 2026-05-01 0001166708 BWMG:BlakeCarmichaelMember 2026-05-31 2026-05-31 0001166708 BWMG:RobertCarmichaelMember 2025-01-01 2025-12-31 0001166708 BWMG:RobertCarmichaelMember 2026-06-10 2026-06-10 0001166708 BWMG:CharlesFHyattMember 2026-06-10 2026-06-10 0001166708 BWMG:RobertCarmichaelMember 2026-01-01 2026-03-31 0001166708 BWMG:CharlesFHyattMember 2026-01-01 2026-03-31 0001166708 BWMG:CharlesFHyattMember 2026-06-30 2026-06-30 0001166708 BWMG:RobertCarmichaelMember 2026-06-30 2026-06-30 0001166708 BWMG:BlakeCarmichaelMember 2026-06-30 2026-06-30 0001166708 BWMG:ConvertibleNotesHolderMember 2026-06-30 2026-06-30 0001166708 BWMG:ConvertibleNotesHolderMember 2026-04-01 2026-06-30 0001166708 BWMG:BlakeCarmichaelMember 2026-07-31 2026-07-31 0001166708 BWMG:BlakeCarmichaelMember 2026-08-31 2026-08-31 0001166708 BWMG:BlakeCarmichaelMember 2026-09-30 2026-09-30 0001166708 BWMG:RobertCarmichaelMember 2026-01-01 2026-09-30 0001166708 BWMG:CharlesFHyattMember 2026-01-01 2026-09-30 0001166708 BWMG:MikkelPitznerMember 2026-01-01 2026-09-30 0001166708 BWMG:ConvertibleNotesHolderMember 2026-01-01 2026-09-30 0001166708 BWMG:ConvertibleNotesHolderMember 2026-07-01 2026-09-30 0001166708 2010-06-30 0001166708 BWMG:SeriesAConvertiblePreferredStockMember 2011-04-30 0001166708 BWMG:SeriesAConvertiblePreferredStockMember 2011-04-01 2011-04-30 0001166708 BWMG:SeriesAConvertiblePreferredStockMember BWMG:RobertCarmichaelMember 2026-09-30 0001166708 BWMG:SeriesAConvertiblePreferredStockMember BWMG:RobertCarmichaelMember 2025-12-31 0001166708 BWMG:EquityIncentivePlanMember 2021-05-26 0001166708 us-gaap:OptionMember 2026-09-30 0001166708 BWMG:EquityCompensationApprovedPlanMember BWMG:SecurityHoldersMember 2026-09-30 0001166708 BWMG:EquityCompensationNotApprovedPlanMember BWMG:SecurityHoldersMember 2026-09-30 0001166708 srt:MinimumMember 2026-01-01 2026-09-30 0001166708 srt:MaximumMember 2026-01-01 2026-09-30 0001166708 srt:MinimumMember 2025-01-01 2025-09-30 0001166708 srt:MaximumMember 2025-01-01 2025-09-30 0001166708 2024-01-01 2024-12-31 0001166708 2025-01-01 2025-12-31 0001166708 2026-06-30 0001166708 2026-01-01 2026-06-30 0001166708 us-gaap:WarrantMember 2025-12-31 0001166708 us-gaap:WarrantMember 2025-01-01 2025-12-31 0001166708 us-gaap:WarrantMember 2026-01-01 2026-09-30 0001166708 us-gaap:WarrantMember 2026-09-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2020-06-30 2020-06-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2019-12-01 2019-12-31 0001166708 2019-12-01 2019-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2022-01-01 2022-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2023-01-01 2023-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2024-01-01 2024-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:FiscalYearTwoThousandAndTwentyTwoThroughTwoThousandAndTwentyFourMember 2025-01-24 2025-01-24 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:FiscalYearTwoThousandAndTwentyTwoThroughTwoThousandAndTwentyFourMember 2025-02-07 2025-02-07 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:FiscalYearTwoThousandAndTwentyTwoThroughTwoThousandAndTwentyFourMember 2024-01-01 2024-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:FiscalYearTwoThousandAndTwentyTwoThroughTwoThousandAndTwentyFourMember 2025-01-01 2025-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:FiscalYearTwoThousandAndTwentyTwoThroughTwoThousandAndTwentyFourMember 2026-01-01 2026-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:DecemberThirtyOneTwoThousandAndTwentyThreeMember 2020-06-30 2020-06-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember BWMG:YearsTwoThousandAndNineteenThroughTwoThousandAndTwentyFourMember 2020-06-30 2020-06-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2022-11-01 2022-11-01 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2025-01-01 2025-12-31 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2026-09-30 0001166708 BWMG:PatentLicenseAgreementMember BWMG:SetayshaTechnicalSolutionsLLCMember 2025-12-31 0001166708 BWMG:BlakeCarmichaelAgreementMember 2021-08-01 2021-08-01 0001166708 BWMG:BlakeCarmichaelAgreementMember 2021-08-01 0001166708 BWMG:BlakeCarmichaelAgreementOneMember 2021-08-01 2021-08-01 0001166708 BWMG:BlakeCarmichaelAgreementOneMember srt:MaximumMember 2021-08-01 0001166708 BWMG:BlakeCarmichaelAgreementOneMember 2021-08-01 0001166708 BWMG:BubanAgreementMember 2021-09-03 2021-09-03 0001166708 BWMG:BubanAgreementMember 2021-09-03 0001166708 BWMG:BubanAgreementMember srt:MaximumMember 2021-09-03 0001166708 BWMG:BubanAgreementMember BWMG:FiveYearStockOptionMember 2021-09-03 0001166708 BWMG:CroneLawGroupMember 2022-01-17 2022-01-17 0001166708 BWMG:GagasEmploymentAgreementMember 2022-05-02 2022-05-02 0001166708 2022-05-02 2022-05-02 0001166708 2022-09-14 2022-09-14 0001166708 2022-09-14 0001166708 2022-09-30 2022-09-30 0001166708 2022-12-22 2022-12-22 0001166708 2023-01-01 2023-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure BWMG:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

 

(Mark One)

 

  ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
     
    For the quarterly period ended September 30, 2026

 

or

 

  ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
     
    For the transition period from to

 

Commission file number: 333-99393

 

BROWNIE’S MARINE GROUP, INC.

(Exact name of registrant as specified in its charter)

 

Florida   90-0226181
(State or other jurisdiction of
incorporation or organization)
 

(I.R.S. Employer

Identification No.)

 

4061 SW 47th Ave. Davie, Florida   33314
(Address of principal executive offices)   (Zip code)

 

(954) 462-5570

Registrant’s telephone number, including area code

 

Former name, former address and former fiscal year, if changed since last report

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
None   Not applicable   Not applicable

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
  Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

 

As of November 4, 2026, there were 561,595,604 shares of common stock outstanding.

 

 

 

 
 

 

TABLE OF CONTENTS

 

    Page No.
  PART I – FINANCIAL INFORMATION  
     
ITEM 1. FINANCIAL STATEMENTS. 4
     
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. 23
     
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. 26
     
ITEM 4. CONTROLS AND PROCEDURES. 26
     
  PART II – OTHER INFORMATION  
     
ITEM 1. LEGAL PROCEEDINGS. 28
     
ITEM 1A. RISK FACTORS. 28
     
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS. 28
     
ITEM 3. DEFAULTS UPON SENIOR SECURITIES. 28
     
ITEM 4. MINE SAFETY DISCLOSURES. 28
     
ITEM 5. OTHER INFORMATION. 28
     
ITEM 6. EXHIBITS. 29

 

2
 

 

NOTE REGARDING FORWARD-LOOKING INFORMATION

 

This Quarterly Report includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “targets,” “likely,” “aim,” “will,” “would,” “could,” and similar expressions or phrases identify forward- looking statements. We have based these forward-looking statements largely on our current expectations and future events and financial trends that we believe may affect our financial condition, results of operation, business strategy and financial needs.

 

You should read thoroughly this Quarterly Report with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by risk factors included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on April 10, 2026, which risk factors could adversely impact our business and financial performance. New risk factors emerge from time to time and it is not possible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. All forward-looking statements speak only as of the date on which they are made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they are made, except as required by applicable law.

 

3
 

 

PART I

 

ITEM 1. FINANCIAL STATEMENTS

 

BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

  

September 30,

2026

  

December 31,

2025

 
   (Unaudited)     
ASSETS          
Current Assets          
Cash  $790,026   $307,886 
Accounts receivable – net of allowances of $29,048 at September 30, 2026 and $20,552 at December 31, 2025   401,773    189,431 
Accounts receivable - related parties   50,331    20,492 
Inventory, net   2,948,866    2,339,931 
Prepaid expenses and other current assets   361,212    182,373 
Total current assets   4,552,209    3,040,113 
           
Property, equipment and leasehold improvements, net   228,259    237,835 
Operating lease right-of-use assets   3,020,611    1,200,507 
Intangible assets, net   386,749    441,099 
Goodwill   302,717    249,986 
Other assets   88,821    51,826 
           
Total assets  $8,579,367   $5,221,366 
           
Liabilities and stockholders’ equity          
Current liabilities          
Accounts payable and accrued liabilities  $933,165   $585,531 
Accounts payable - related parties   27,285    12,972 
Customer deposits and unearned revenue   188,747    156,036 
Other liabilities   159,106    157,188 
Operating lease liabilities   534,309    484,078 
Related party convertible demand note, net   -    29,717 
Convertible notes   358,663    355,543 
Current maturities long term debt   -    174,975 
Related party notes payable   489,500    505,000 
Total current liabilities  $2,690,775   $2,461,040 
           
Loans payable, net of current portion   72,399    31,197 
Operating lease liabilities   2,507,208    794,857 
Total liabilities  $5,270,382   $3,287,094 
           
Commitments and contingent liabilities (see note 8)   -      
           
Stockholders’ equity          
Preferred stock; $0.001 par value: 10,000,000 shares authorized; 425,000 issued and outstanding as of September 30, 2026 and December 31, 2025.   425    425 
Common stock; $0.0001 par value; 1,000,000,000 shares authorized; 561,596,098 shares issued and 561,595,604 shares outstanding at September 30, 2026 and 503,267,154 shares issued and outstanding at December 31, 2025.   56,161    50,328 
Common stock payable 138,941 shares as of September 30, 2026 and December 31, 2025.   14    14 
Additional paid-in capital   20,200,896    19,914,863 
Accumulated deficit   (16,948,511)   (18,031,358)
Total stockholders’ equity  $3,308,985   $1,934,272 
           
Total liabilities and stockholders’ equity  $8,579,367   $5,221,366 

 

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements

 

4
 

 

BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF OPERATIONS

(unaudited)

 

    2026     2025     2026     2025  
   

Three months ended

September 30,

   

Nine months ended

September 30,

 
    2026     2025     2026     2025  
Revenues                        
Revenues   $ 2,414,290     $ 1,832,108     $ 6,569,971     $ 5,607,584  
Revenues - related parties     228,035       239,056       565,489       511,673  
                                 
Total Revenues     2,642,325       2,071,164       7,135,460       6,119,257  
                                 
Cost of revenues                                
Cost of revenues     1,102,669       955,836       3,185,272       3,438,320  
Cost of revenues - related parties     109,938       112,635       222,221       225,121  
Royalties expense - related parties     24,107       18,244       50,316       34,161  
Royalties expense     42,552       22,622       110,492       70,939  
Total cost of revenues     1,279,265       1,109,337       3,568,300       3,768,541  
                                 
Gross profit     1,363,060       961,827       3,567,160       2,350,716  
Operating expenses                                
Selling, general and administrative     1,036,547       828,591       3,254,022       2,130,707  
Research and development costs     15,789       298       24,132       2,946  
                                 
Total operating expenses     1,052,336       828,889       3,278,154       2,133,653  
                                 
Income from operations     310,724       132,938       289,006       217,063  
                                 
Other income / gain on settlement of debt     377,576       114,315       1,228,604       114,315  
                                 
Interest expense     (28,606 )     (55,587 )     (146,228 )     (53,804 )
                                 
Income (Loss) before provision for income taxes     659,694       191,666       1,371,382       277,574  
                                 
Provision for income taxes     -       -       -       -  
                                 
Net Income (Loss)   $ 659,694     $ 191,666     $ 1,371,382     $ 277,574  
                                 
Basic income (loss) per common share   $ .00119     $ .00043     $ .00262     $ .00062  
Basic weighted average common shares outstanding     556,353,166       450,656,081       523,186,280       450,932,137  
Diluted income (loss) per common share   $ .00118     $ .00043     $ .00262     $ .00062  
Diluted weighted average common shares outstanding     556,853,305       450,656,081       524,308,486       450,932,137  

 

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements

 

5
 

 

BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

(unaudited)

 

Nine Months Ended September 30, 2025 (Comparative Period)

 

   Shares   Amount   Shares   Par   Shares   Amount   Capital   Deficit   (Deficit) 
   Preferred Stock   Common Stock   Common Stock
Payable
   Additional
Paid-in
   Accumulated   Total
Stockholders’
Equity
 
   Shares   Amount   Shares   Par   Shares   Amount   Capital   Deficit   (Deficit) 
                                     
Balance, December 31, 2024   425,000   $425   $449,430,935   $44,944   $138,941   $14   $19,460,786   $(17,926,209)  $1,579,960 
Shares issued for accrued interest on convertible notes            $409,581   $41   $-        $20,959   $-   $21,000 
Shares issued for professional services                 $-   $-        $-        $- 
Shares issued for salary reduction   -    -    3,654,006    365    -    -    25,135   $-   $25,500 
Stock option expense                                     $-      
Shares issued for BOD compensation             -                       $-   $- 
Shares issued for signing bonus / other employee compensation                                             
Other equity transaction                                           - 
Net income (loss)                                      277,574    277,574 
Balance, September 30, 2025 (unaudited)   425,000    425    453,494,522    45,350    138,941    14    19,506,880    (17,648,635)   1,904,034 

 

Nine Months Ended September 30, 2026 (Current Period)

 

   Shares   Amount   Shares   Par   Shares   Amount   Capital   Deficit   (Deficit) 
   Preferred Stock   Common Stock   Common Stock Payable   Additional Paid-in   Accumulated   Total Stockholders’ Equity 
   Shares   Amount   Shares   Par   Shares   Amount   Capital   Deficit   (Deficit) 
Balance, December 31, 2025   425,000   $425    503,267,154   $50,328    138,941   $14   $19,914,863   $(18,031,358)  $1,934,272 
Shares issued for accrued interest on convertible notes             409,581   $41    -        $20,959   $-   $21,000 
Shares issued for professional services                                          $- 
Shares issued for salary reduction   -    -    5,241,288   $524    -    -   $24,976        $25,500 
Stock option expense                                          $- 
Shares issued for BOD compensation             8,115,577    812              33,688        $34,500 
Shares issued for signing bonus / other employee compensation             2,562,500    256    -         15,410         15,667 
Sunrise Paddleboards acquisition             42,000,000    4,200    -         185,000         189,200 
Prior-period accounting adjustments                                 6,000    (288,535)   (282,535)
Net income (loss)                                      1,371,382    1,371,382 
Balance, September 30, 2026 (unaudited)   425,000    425    561,596,098    56,161    138,941   14    20,200,896    (16,948,511)   3,308,985 

 

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements

 

6
 

 

BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30,

(unaudited)

 

   2026   2025 
Cash flows from operating activities:          
Net income (loss)  $1,371,382   $277,574 
Prior-period accounting adjustments   (282,535)   - 
Depreciation and amortization — property and equipment   63,904    42,971 
Amortization — intangible assets   54,350    54,350 
Noncash interest and debt discount adjustments   3,120    (7,543)
Amortization of right-of-use asset   383,987    315,288 
Stock-based compensation — options   -    - 
Stock/share compensation and services   75,667    25,500 
Shares issued for accrued convertible-note interest   20,999    21,000 
Gain on lease termination / noncash lease derecognition   (59,503)   - 
Gain on debt extinguishment / forgiveness   (155,078)   - 
Bad-debt reserve / recovery   -    - 
Inventory reserve / recall adjustment   -    - 
Other noncash operating adjustments   325    - 
Changes in operating assets and liabilities:          
Change in accounts receivable, net   (212,342)   (9,455)
Change in accounts receivable - related parties   (29,839)   (8,694)
Change in inventory   (482,542)   (188,438)
Change in prepaid expenses and other current assets   (178,839)   (7,139)
Change in other assets   (32,225)   - 
Change in accounts payable and accrued liabilities  $490,023   $(36,837)
Change in customer deposits and unearned revenue   32,711    (127,773)
Change in operating lease assets and liabilities   (382,006)   (282,564)
Change in other liabilities   15,445    (13,845)
Change in accounts payable - related parties   14,313    7,469 
Net cash provided by operating activities   711,316    61,865 
Cash flows from investing activities:          
Business/asset acquisition, net cash acquired   306    - 
Purchase of property and equipment   (29,328)   - 
Net cash used in investing activities   (29,022)   - 
Cash flows from financing activities:          
Proceeds of debt  $21,125    - 
Repayment of related party convertible demand note   (29,717)   - 
Repayment of loans and notes payable  $(176,062)  $- 
Repayment of related party notes payable   (15,500)   - 
Net cash used in financing activities   (200,153)   - 
Net increase (decrease) in cash  $482,140   $61,865 
Cash, beginning balance   307,886    417,678 
Cash, end of period   790,026    479,543 
Supplemental disclosures of cash flow information:          
Cash paid for interest  $5,661   $13,297 
Cash paid for operating lease liabilities  $443,886    363,415 
Cash paid for income taxes   17,303    - 
Supplemental disclosure of non-cash investing and financing activities:          
Operating lease right-of-use assets and liabilities established   2,779,582    - 
Equipment obtained through financing   20,000    - 
Shares issued for services and compensation   75,667    25,500 
Shares issued for convertible note interest  $20,999   $21,000 

 

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements

 

7
 

 

BROWNIE’S MARINE GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS SEPTEMBER 30, 2026

(UNAUDITED)

 

Note 1. Company Overview

 

Brownie’s Marine Group, Inc. (the “Company”) designs, tests, manufactures and distributes recreational hookah diving, scuba, and water safety products through its wholly owned subsidiary, Trebor Industries, Inc., a Florida corporation, incorporated in 1981 (“Trebor” or “BTL”), manufactures and sells high pressure air and industrial compressor packages, yacht based scuba air compressor and nitrox generation systems through its wholly owned subsidiary, Brownie’s High Pressure Compressor Services, Inc., a Florida corporation incorporated in 2017 (“BHP”) and doing business as LW Americas (“LWA”) and develops and markets portable battery powered surface supplied air dive systems through its wholly owned subsidiary BLU3, Inc., a Florida corporation (“BLU3”). On September 3, 2021, the Company, entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) with Submersible Acquisition, Inc., a Florida corporation and wholly owned subsidiary of the Company (“Acquisition Sub”), Submersible Systems, Inc., a Florida corporation (“Submersible” or “SSI”), and Summit Holdings V, LLC, a Florida limited liability company (“Summit”) and Tierra Vista Group, LLC, a Florida limited liability company (“Tierra Vista” and, together with Summit, the “Sellers”), the owners of all of the capital stock of Submersible, pursuant to which Acquisition Sub merged with and into Submersible (the “Merger”), and Submersible, the surviving corporation, became a wholly owned subsidiary of the Company.

 

Submersible is a manufacturer of high pressure tanks and redundant air systems for the military and recreational diving industries, based in Huntington Beach, California and sells its products to governments, militaries, private companies and the dive industry throughout the world.

 

On February 13, 2022 the Company filed with the Florida Department of State, the articles of incorporation for a new wholly owned subsidiary, Live Blue, Inc. (“LBI”). LBI utilizes technology developed by BLU3 to provide new users and interested divers a guided tour experience. On May 2, 2022, the Company entered into an asset purchase agreement (the “Asset Purchase Agreement”) with Gold Coast Scuba, LLC, a Florida limited liability company (“Gold Coast Scuba”), Steven M. Gagas and William Frenier, the sole members of Gold Coast Scuba (together, the “LLC Members”) and LBI. Pursuant to the terms of the Asset Purchase Agreement, LBI acquired substantially all of Gold Coast Scuba’s assets and assumed certain non-material liabilities of the business associated with these assets. In addition, LBI assumed the lease for the premises for Gold Coast Scuba as part of this asset acquisition.

 

On July 1, 2026, the Company executed and consummated the transactions contemplated by an asset purchase agreement (the “Sunrise Paddleboards Asset Purchase Agreement”) by and among Sunrise Paddleboards LLC, a Florida limited liability company (“Sunrise Paddleboards”), Brian Galton, the sole member of Sunrise Paddleboards (the “LLC Member”), the Company and Live Blue, Inc. (“LBI”). Pursuant to the terms of the Asset Purchase Agreement, LBI acquired substantially all of Sunrise Paddleboards’ assets and assumed certain liabilities of the business associated with these assets. Sunrise Paddleboards is in the business of providing paddleboarding and kayaking experiences, including paddleboard rental, tour, retail and training. In consideration for the assets purchased, the Company issued 42,000,000 shares of its common stock to the LLC Member and, in connection with the acquisition, 1,000,000 shares to an employee of Sunrise Paddleboards, each at a price of $0.0044 per share, based upon the closing price of the Company’s common stock on the OTC Markets on June 30, 2026.

 

Note 2. Basis of Presentation and Summary of Significant Accounting Policies

 

Basis of Presentation

 

The unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, such interim financial statements do not include all the information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete annual financial statements. The information furnished reflects all adjustments, consisting only of normal recurring items which are, in the opinion of management, necessary in order to make the financial statements not misleading. The balance sheet as of December 31, 2025 has been derived from the Company’s annual financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 for a broader discussion of the Company’s business and the risks inherent in such business. The results of operations for the nine months ended September 30, 2026, are not necessarily indicative of results to be expected for any other interim period or the fiscal year ending December 31, 2026.

 

During the nine months ended September 30, 2026, the Company identified and corrected accounting errors related to the correction of certain prior-period accounting matters. These adjustments affected various balance sheet and income statement accounts and were reflected in the underlying account balances presented in the financial statements. The corresponding amount included within the statement of cash flows represents the impact of these prior-period adjustments and related reclassifications.

 

For purposes of clarity and ease of presentation, all dollar amounts in these financial statements have been rounded to the nearest whole number. However, the underlying data used in the calculations is not rounded, and the totals presented may differ by a small amount due to rounding. These differences are considered immaterial and do not affect the overall financial position or results of operations.

 

8
 

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Trebor, BHP, BLU3, SSI and LBI. All significant intercompany transactions and balances have been eliminated in consolidation.

 

Use of estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and cash equivalents

 

Only highly liquid investments with original maturities of 90 days or less are classified as cash and equivalents. These investments are stated at cost, which approximates market value.

 

Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 per EIN. At September 30, 2026 and December 31, 2025, the Company had approximately $73,000 and $25,000, respectively, in excess of the FDIC insured limit.

 

Accounts receivable

 

The Company manufactures and sells its products to a broad range of customers, primarily retail stores. Few customers are provided with payment terms of 30 days. The Company has tracked historical loss information for its trade receivables and compiled historical credit loss percentages for different aging categories (current, 1–30 days past due, 31–60 days past due, 61–90 days past due, and more than 90 days past due).

 

In accordance with ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), management believes that although, the Company had historical loss information, the Company is showing improvements in cash sales and collections of accounts receivable. Although the composition of the trade receivables at that date is consistent with that used in developing the historical credit-loss percentages (i.e., the similar risk characteristics of its customers and its lending practices have not changed significantly over time). Accordingly, the allowance for expected credit losses at September 30, 2026, and December 31, 2025, totaled $29,048 and $20,552, respectively. The allowance for doubtful accounts increased due to an increase in trade accounts receivable.

 

Inventory

 

Inventory consists of the following:

 

  

September 30,

2026

  

December 31,

2025

 
         
Raw materials  $1,656,266   $1,477,422 
Work in process   70,920    60,401 
Finished goods   1,358,051    978,527 
Rental equipment   -    - 
Allowance excess and obsolete inventory   (136,370)   (176,419)
Inventory, net  $2,948,866   $2,339,931 

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers. The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. The Company typically satisfies its performance obligations in contracts with customers upon shipment of the goods. Generally, payment is due upon receipt of the invoice and the contracts do not have significant financing components. Product sales occur once control or title is transferred based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and promotional allowances. Such provisions are calculated based on the actual allowances given. Management believes that adequate provision has been made for cash discounts, returns, spoilage and promotional allowances based on the Company’s historical experience.

 

9
 

 

A breakdown of the total revenue between related party and non-related party revenue is as follows:

 

       
   Nine months ended September 30, 
   2026   2025 
   (unaudited)   (unaudited) 
Revenues  $6,569,971   $5,607,584 
Revenues - related parties   565,489    511,673 
Total Revenues  $7,135,460   $6,119,257 

 

   2026   2025 
   Three months ended September 30, 
   2026   2025 
   (unaudited)   (unaudited) 
Revenues  $2,414,290   $1,832,108 
Revenues - related parties   228,035    239,056 
Total Revenues  $2,642,325   $2,071,164 

 

Cost of Sales

 

Cost of sales consists of the cost of the components of finished goods, the costs of raw materials utilized in the manufacture of products, in-bound and out- bound freight charges, direct manufacturing labor as well as certain internal transfer costs, warehouse expenses incurred prior to the manufacture of the Company’s finished products, inventory allowance for excess and obsolete inventory, and royalties paid on licensing agreements. Components account for the largest portion of the cost of sales. Components include plastic molded parts, gas powered engines, aluminum pressure bottles, electronic parts, batteries and packaging materials.

 

The breakdown of cost of sales to include cost of sales for related party and non-related party as well as the related party and non-related party royalty expense is as follows:

 

   2026   2025 
   Nine months ended September 30, 
   2026   2025 
   (unaudited)   (unaudited) 
Cost of revenues  $3,185,272   $3,438,320 
Cost of revenues - related parties   222,221    225,121 
           
Royalties expense - related parties   50,316    34,161 
Royalties expense   110,492    70,939 
Total cost of revenues  $3,568,300   $3,768,541 

 

Lease Accounting

 

The Company accounts for leases in accordance with ASC 842, Leases.

 

The lease standard requires all leases to be reported on the balance sheet as right-of-use assets and lease obligations. The Company elected the practical expedients permitted under the transition guidance of the new standard that retained the lease classification and initial direct costs for any leases that existed prior to adoption of the standard. The Company did not reassess whether any contracts entered into prior to adoption are leases or contain leases.

 

The Company categorizes leases with contractual terms longer than twelve months as either operating or finance. Finance leases are generally those leases that would allow the Company to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property and equipment. All other leases are categorized as operating leases. The Company did not have any finance leases as of September 30, 2026. The Company’s leases generally have terms that range from three years for equipment and five to twenty years for property. The Company elected the accounting policy to include both the lease and non-lease components of its agreements as a single component and account for them as a lease.

 

Operating lease liabilities are recognized at the present value of the fixed lease payments using a discount rate based on similarly secured borrowings available to the Company. Operating lease right-of-use (“ROU”) assets are recognized based on the initial present value of the fixed lease payments, reduced by landlord incentives, plus any direct costs from executing the leases. Operating lease ROU assets are tested for impairment in the same manner as long-lived assets used in operations. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term.

 

10
 

 

When the Company has the option to extend the lease term, terminate the lease for the contractual expiration date, or purchase the leased asset, and it is reasonably certain that the Company will exercise the option, it considers these options in determining the classification and measurement of the lease. Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease.

 

For the nine months ended September 30, 2026 and September 30, 2025, cash paid for operating lease liabilities was $443,886 and $363,415, respectively.

 

Supplemental balance sheet information related to leases was as follows:

 

Operating Leases 

September 30,

2026

 
   (unaudited) 
Right-of-use assets  $3,020,611 
Current lease liabilities  $534,309 
Non-current lease liabilities   2,507,208 
Total lease liabilities  $3,041,516 

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation. ASC 718 requires companies to measure the cost of employee and non-employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee and non-employee are required to provide service in exchange for the award, usually the vesting period.

 

The Company uses the Black-Scholes valuation model to calculate the fair value of options and warrants issued to both employees and non-employees. Stock issued for compensation is valued on the effective date of the agreement in accordance with generally accepted accounting principles, which includes determination of the fair value of the share-based transaction. The fair value is determined through use of the quoted stock price.

 

Derivatives

 

The accounting treatment of derivative financial instruments requires that the Company record certain warrants and embedded conversion options at their fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. As a result of entering into certain note agreements, for which such instruments contained a variable conversion feature with no floor, the Company has adopted a sequencing policy, by earliest issuance date, in accordance with ASC 815-40-35-12 whereby all future instruments may be classified as a derivative liability with the exception of instruments related to share-based compensation issued to employees or directors, as long as the certain variable issuance terms in certain convertible instruments exist. As of September 30, 2026, and December 31, 2025, the Company did not have any derivative liabilities.

 

Loss (Income) per share of common stock

 

Basic loss per share excludes any dilutive effects of options, warrants and convertible securities. Basic earnings per share is computed using the weighted-average number of outstanding common shares during the applicable period. Diluted earnings per share is computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. For the three months ended September 30, 2026, net income was $659,694 with basic weighted average shares outstanding of 556,353,166, resulting in basic earnings per share of $0.00119. For the nine months ended September 30, 2026, net income was $1,371,382 with basic weighted average shares outstanding of 523,186,280, resulting in basic earnings per share of $0.00262. For the three months ended September 30, 2025, net income was $191,666 with basic weighted average shares outstanding of 450,656,081, resulting in basic earnings per share of $0.00043. For the nine months ended September 30, 2025, net income was $277,574 with basic weighted average shares outstanding of 450,932,137, resulting in basic earnings per share of $0.00062.

 

11
 

 

Comparative Period Detail

 

Period  Net Income   WASO   EPS 
Three months ended September 30, 2026  $659,694    556,353,166   $0.00119 
Three months ended September 30, 2025  $191,666    450,656,081   $0.00043 
Nine months ended September 30, 2026  $1,371,382    523,186,280   $0.00262 
Nine months ended September 30, 2025  $277,574    450,932,137   $0.00062 

 

Recent accounting pronouncements

 

ASU 2016-13 Current Expected Credit Loss (ASC326)

 

In December 2021, the FASB issued an update to ASU No. 2016-13 the Current Expected Credit Losses (CECL) standard (ASC 326), which is designed to provide greater transparency and understanding of credit risk by incorporating estimated, forward-looking data when measuring lifetime Estimated Credit Losses (ECL) and requires enhanced financial statement disclosures. This guidance was adopted on January 1, 2023, with no effect to the financial statements.

 

ASU 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) - Accounting for Convertible Instruments and Contracts on an Entity’s Own Equity.

 

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) - Accounting for Convertible Instruments and Contracts on an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exceptions. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early adoption is permitted. The Company is currently evaluating the impact of the adoption of the standard on the consolidated financial statements.

 

Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption or are not applicable.

 

Note 3. Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis. Although the Company reported net income of $1,371,382 for the nine months ended September 30, 2026 and had a working capital surplus of approximately $1.9 million, the Company continues to have an accumulated deficit of approximately $16.9 million and a history of operating losses. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the consolidated financial statements are issued. Management’s plans to alleviate this substantial doubt include increasing revenues, controlling operating expenses, and obtaining additional capital as needed. However, there can be no assurance that these plans will be successful. Accordingly, substantial doubt about the Company’s ability to continue as a going concern remains. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Note 4. Related Party Transactions

 

The Company sells products to Brownie’s Southport Divers, Brownie’s Yacht Toys and Brownie’s Palm Beach Divers, companies owned by the brother of Robert Carmichael, the Company’s Chief Executive Officer and Chief Financial Officer. Terms of sale are no more favorable than those extended to any of the Company’s other customers with similar sales volumes. Related-party revenues accounted for 7.9% and 8.4% of total revenues for the nine months ended September 30, 2026 and September 30, 2025, respectively. Accounts receivable from related parties totaled $50,331 and $20,492 at September 30, 2026 and December 31, 2025, respectively.

 

12
 

 

The Company sells products to Brownies Global Logistics (“BGL”) and 940 Associates (“940 A”), entities wholly-owned by Robert Carmichael. Terms of sale are more favorable than those extended to the Company’s regular customers, but no more favorable than those extended to the Company’s strategic partners. Accounts receivable from BGL and 940 A totaled $2,722 and $0 at September 30, 2026 and December 31, 2025, respectively.

 

The Company had accounts payable to related parties of $27,285 and $12,972 at September 30, 2026 and December 31, 2025, respectively. The balance payable at September 30, 2026 was comprised of $12,980 due to BGL, $11,520 due to Robert Carmichael and $2,786 due to Blake Carmichael. At December 31, 2025, the balance payable was comprised of $9,992 due to Robert Carmichael and $2,980 due to BGL.

 

The Company has exclusive license agreements with 940 A to license the trademark “Brownie’s Third Lung”, “Tankfill”, “Brownie’s Public Safety” and various other related trademarks as listed in the agreements. The agreements provide that the Company pay 2.5% of gross revenues per quarter as a royalty to 940A. Related-party royalty expense for the nine months ended September 30, 2026 and September 30, 2025 was $50,316 and $34,161, respectively. The accrued royalty at September 30, 2026 and December 31, 2025 was $0 and $2,450, respectively, which is included in other liabilities.

 

On September 30, 2022, the Company issued a convertible demand 8% promissory note in the principal amount of $66,793 to Robert Carmichael for funds to meet the working capital needs of LBI. There is no amortization schedule for the note, and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day value weighted average price (“VWAP”) of the Company’s stock prior to the quarterly interest payment date. The note holder may demand payment or convert the outstanding principal at a conversion rate of $0.021 per share at any time. The conversion rate was calculated at a 35% discount to the 90 day VWAP of the Company’s stock as of the date of the note. The Company recorded $19,250 for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability. The outstanding balance on this note was $0 as of September 30, 2026.

 

On January 18, 2023 and February 18, 2023, the Company issued to Charles Hyatt, a Company director, an aggregate of 11,428,570 units, with each unit consisting of one share of common stock and a two-year warrant to purchase one share of common stock at an exercise price of $0.0175 per share in consideration of $200,000.

 

On September 14, 2023, the Company issued a convertible demand promissory note in the principal amount of $50,000 to Robert Carmichael for funds to meet the working capital needs of BLU3. There is no amortization schedule for the note as the note is interest free. The Company recorded $0 for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability.

 

On November 14, 2023, the Company borrowed funds through the issuance of a promissory note in the principal amount of $150,000 to Charles Hyatt, a Company director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The balance of $150,000 was outstanding as of December 31, 2025, and the maturity date was extended from May 7, 2025 to November 5, 2025, pursuant to an amendment dated November 13, 2025.

 

The note bears interest at a rate of 9.9% per annum, and has a default interest of 18% per annum. Interest payments are due and payable on a monthly basis. The Company may prepay the Note in whole or in part, at any time without premium or penalty.

 

On December 23, 2023, the Company issued a demand promissory note in the principal amount of $25,000 to Robert Carmichael for funds to meet the working capital needs of BLU3. There is no amortization schedule for the note as the note is interest free. The Company recorded $0 for the beneficial conversion feature. As this conversion rate is a fixed rate, the embedded conversion feature is not a derivative liability. The aggregate outstanding balance of the BLU3 demand notes payable to Mr. Carmichael was $59,500 as of September 30, 2026.

 

On February 5, 2025, the Company borrowed funds through the issuance of a promissory note (the Note) in the principal amount of $280,000 to Charles Hyatt, a Company director, for working capital requirements and payment of certain expenses in connection with the Company’s business combinations. The balance of $280,000 was outstanding as of December 31, 2025, and the maturity date was extended from August 6, 2025 to November 5, 2025, pursuant to an amendment dated November 13, 2025.

 

The note bears interest at a rate of 9.9% per annum, and has a default interest of 18% per annum. Interest payments are due and payable on a monthly basis. The Company may prepay the note in whole or in part, at any time without premium or penalty.

 

13
 

 

On June 8, 2026, the Company recorded $103,043 as interest expense. The interest expense was for a note for $280,000 as of February 5, 2025, and a note for $150,000 as of November 14, 2023.

 

On March 31, 2023, the Company issued 61,204 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending March 31, 2023. The fair value of these shares was $1,336.

 

On June 30, 2023, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2023. The fair value of these shares was $1,287.

 

On September 30, 2023, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending September 30, 2023. The fair value of these shares was $1,287.

 

On December 31, 2023, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending December 31, 2023. The fair value of these shares was $1,287.

 

On March 31, 2025, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending March 31, 2025. The fair value of these shares was $1,287.

 

On July 16, 2025, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2025. The fair value of these shares was $1,287.

 

On December 9, 2025, the Company issued 8,241,759 shares of common stock to Blake Carmichael, the chief executive officer of BLU3, as compensation for a reduction in salary. The fair value of these shares was $60,000.

 

Note 5. Convertible Promissory Notes and Loans Payable

 

Convertible Promissory Notes

 

Convertible promissory notes consisted of the following at September 30, 2026:

 

Origination Date  Maturity Date  Interest Rate   Origination Principal Balance   Original Discount Balance   Period End Principal
Balance
   Period End Discount
Balance
   Payments   Period End Balance Note 
9/03/21  9/03/24   8%   346,500    (12,355)  $346,500   $8,580   $     -    355,080(1)
9/03/21  9/03/24   8%   3,500    (125)   3,500    83    -    3,583(2)
9/30/22  Demand   8%   66,793    (19,250)   -    -    -    -(3)
                     $350,000   $8,663   $-   $358,663 

 

 

Current and long-term amounts due are as follows for the convertible promissory notes as of September 30, 2026:

 

   Summit
Holdings V,
LLC Note
   Tierra Vista
Partners,
LLC Note
   Robert
Carmichael
Note
   Total 
   (1)   (2)   (3)     
2026  $346,500   $3,500   $-   $350,000 
Discount and payments   8,580    83               -   $8,663 
Total Loan Payments  $355,080   $3,583   $-   $358,663 
Current Portion of Loan Payable  $(355,080)  $(3,583)  $-   $(358,663)
Non-Current Portion of Loan Payable  $-   $-   $-   $- 

 

(1) On September 3, 2021, the Company issued a three-year 8% convertible promissory note in the principal amount of $346,500 to Summit Holding V, LLC as part of the acquisition of SSI. The Company is required to make quarterly payments under the note in an amount equal to 50% of the adjusted net profit of SSI. Interest is payable quarterly in shares of common stock of the Company at a conversion price of $0.051272 per share. The note holder may convert outstanding principal and interest into shares of common stock at a conversion price of $0.051272 per share at any time during the term of the note. The Company recorded $12,355 for the beneficial conversion feature. This note is classified as a current liability for the nine months ended September 30, 2026. The stated maturity date of the note was September 3, 2024. The Company is working with the lender to finalize an extension of the maturity date and restructure the note.

 

14
 

 

   Payment
Amortization
 
     
2026   - 
Total Note Payments  $346,500 
Current portion of note payable   (346,500)
Non-Current Portion of Notes Payable  $- 

 

(2) On September 3, 2021, the Company issued a three-year 8% promissory note in the principal amount of $3,500 to Tierra Vista Partners, LLC as part of the acquisition of SSI. The Company is required to make quarterly payments under the note in an amount equal to 50% of the adjusted net profit of SSI. Interest is payable quarterly in common stock of the Company at a conversion price of $0.051272 per share. The note holder may convert outstanding principal and interest into shares of common stock at a conversion price of $0.051272 at any time during the term of the note. The Company recorded $125 for the beneficial conversion feature. This note is classified as a current liability for the nine months ended September 30, 2026

 

  The stated maturity date of the note was September 3, 2024. The Company is working with the lender to finalize an extension of the maturity date and restructure the note.

 

   Payment
Amortization
 
     
2026   - 
Total Note Payments  $3,500 
Current portion of note payable   (3,500)
Non-Current Portion of Notes Payable  $- 

 

(3) On September 30, 2022, the Company issued a convertible demand 8% promissory note in the principal amount of $66,793 to Robert Carmichael for funds to meet the working capital needs of LBI. There is no amortization schedule for the note and interest is payable in shares of common stock of the Company at a conversion price equal to the 90 day volume weighted average (VWAP) of the Company’s common stock prior to the quarterly interest payment date. This note is classified as a current liability as the note holder may demand payment or convert the outstanding principal at a conversion price of $0.021 per share at any time. The Company recorded $19,250 for the beneficial conversion feature. The outstanding balance was $0 at September 30, 2026.

 

Loans Payable

 

   Navitas
2024
BLU3
(4)
   Navitas
2026
BLU3
(5)
   Navitas
2026
BTL
(6)
   Bank
United
2026
BLU3
(7)
   Total 
                     
2026  $1,630    1,444    1,155   $1,093   $5,322 
2027  $7,022    6,276    5,002    4,736   $23,036 
2028  $7,899    7,156    5,672    5,387   $26,115 
Thereafter  $1,409    3,271    4,747    8,499   $17,926 
Total Loan Payments  $17,961   $18,147   $16,576   $19,715   $72,399 
Current Portion of Loan Payable  $(6,819)  $(6,073)  $(4,847)  $(4,585)  $(22,324)
Non-Current Portion of Loan Payable  $11,143   $12,074   $11,729   $15,130   $50,075 

 

(4) On February 12, 2024, BLU3 executed an inventory finance agreement to finance the purchase of certain equipment stock through Navitas. The amount financed is $32,274 payable over 60 equal monthly installments of $715. The inventory finance agreement contains customary events of default. The loan balance as of September 30, 2026 was $17,961 and $28,123 as of December 31, 2025.

 

15
 

 

(5) On June 10, 2026 BLU3 executed an equipment finance agreement to finance the purchase of certain plastic molding equipment through Navitas. The amount financed is $20,000 payable over 36 equal monthly installments of $675.87. The equipment finance agreement contains customary events of default. The loan balance as of September 30, 2026 was $18,147.
   
(6) On October 4, 2024, Brownies Third Lung (BTL) executed an inventory finance agreement to finance the purchase of certain equipment stock through Navitas. The amount financed is $24,620 payable over 60 equal monthly installments of approximately $602. The inventory finance agreement contains customary events of default. The loan balance as of September 30, 2026 was $16,576 and $19,831 as of December 31, 2025.
   
(7) On March 23, 2026, BLU3 executed an equipment finance agreement with Bank United to purchase a forklift. The installment agreement is for $21,450, bears interest at 12.87%, and is payable in monthly installments of $574.07 for 48 months. The loan balance as of September 30, 2026 was $19,715. This loan is personally guaranteed by Mr. Carmichael.

 

 

Note 6. Goodwill and Intangible Assets, Net

 

The following table sets for the changes in the carrying amount of the Company’s Goodwill for the nine months ended September 30, 2026

 

   2026 
Balance, January 1  $249,986 
Addition:   52,731 
Balance, September 30, 2026  $302,717 

 

The Company performed an evaluation of the value of goodwill at December 31, 2025. Based upon this evaluation it was determined that there should be no adjustment to goodwill. There has been nothing noted during the nine months ended September 30, 2026 that would indicate that the value of goodwill should change through that date.

 

The following table sets forth the components of the Company’s intangible assets at September 30, 2026:

 

   Amortization
Period (Years)
   Cost   Accumulated Amortization   Net Book Value 
                 
Intangible Assets Subject to Amortization                    
Patents   -    22,160    (22,160)   - 
Trademarks   15    146,177    (64,794)   81,383 
Customer Relationships   10    600,000    (296,100)   303,900 
Non-Compete Agreements   5    22,000    (20,534)   1,466 
Total        790,337    (403,588)   386,749 

 

The aggregate amortization remaining on the intangible assets as of September 30, 2026 is as follows:

 

   Intangible
Assets
Amortization
 
     
2026 (3 months remaining)  $18,117 
2027   68,432 
2028   68,067 
2029   68,067 
2030   68,067 
2031   56,967 
Thereafter   39,032 
Total  $386,749 

 

Amortization expense for amortizable intangible assets for the nine months ended September 30, 2026 and September 30, 2025 was $54,350.

 

16
 

 

Note 7. Stockholders’ Equity

 

Common Stock

 

On January 18, 2023 and February 18, 2023, the Company issued to Charles Hyatt, an aggregate of 11,428,570 units, with each unit consisting of one share of common stock and a two-year warrant to purchase one share of common stock at an exercise price of $0.0175 per share in consideration of $200,000.

 

On March 31, 2023, the Company issued 61,204 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending March 31, 2023. The fair value of these shares was $1,336.

 

On March 31, 2023, the Company issued an aggregate of 137,000 shares of common stock to the holders of convertible notes for payment of interest for the three months ending December 31, 2022. The fair value of these shares was $7,000.

 

On June 30, 2023, the Company issued 61,205 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2023. The fair value of these shares was $1,326.

 

On June 30, 2023, the Company issued an aggregate of 137,000 shares of common stock to the holders of convertible notes for payment of interest for the three months ending June 30, 2023. The fair value of these shares was $7,000.

 

On September 30, 2023, the Company issued 61,205 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending September 30, 2023. The fair value of these shares was $1,326.

 

On September 30, 2023, the Company issued an aggregate of 137,000 shares of common stock to the holders of convertible notes for payment of interest for the three months ending September 30, 2023. The fair value of these shares was $7,000.

 

On December 31, 2023, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending December 31, 2023. The fair value of these shares was $1,287.

 

On December 31, 2023, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending December 31, 2023. The fair value of these shares was $7,000.

 

On March 31, 2025, the Company issued 61,677 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending March 31, 2025. The fair value of these shares was $4,007.

 

On March 31, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending March 31, 2025. The fair value of these shares was $7,000.

 

On June 30, 2025, the Company issued 123,354 shares of common stock to Robert Carmichael for payment of interest on the convertible demand note for the three months ending June 30, 2025. The fair value of these shares was $2,672.

 

On June 30, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending June 30, 2025. The fair value of these shares was $7,000.

 

On August 15, 2025 the Company issued 850,000 shares of common stock to the holders of convertible notes for payment of professional services. The fair market value of these shares was $8,500.

 

On March 31, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending March 31, 2025. The fair value of these shares was $7,000.

 

On December 9, 2025, the Company issued 8,241,759 shares to Blake Carmichael as compensation related to a salary reduction. The fair market value of these shares was $60,000.

 

On December 31, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending December 31, 2025. The fair value of these shares was $7,000.

 

On March 31, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending March 31 2025. The fair value of these shares was $7,000.

 

On June 30, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending June 30, 2025. The fair value of these shares was $7,000.

 

On August 31, 2025, the Company issued an aggregate of 3,302,148 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $22,667.

 

17
 

 

On September 30, 2025, the Company issued an aggregate of 351,958 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $2,833.

 

On September 30, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending September 30, 2025. The fair value of these shares was $7,000.

 

On December 31, 2025, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ending December 31, 2025. The fair value of these shares was $7,000.

 

On December 31, 2025, the Company issued an aggregate of 216,093 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $2,833.

 

On January 31, 2026, the Company issued an aggregate of 440,188 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $2,833.

 

On February 28, 2026, the Company issued an aggregate of 509,704 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $2,833.

 

On March 31, 2026, the Company issued an aggregate of 640,152 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $2,833.

 

On March 31, 2026, the Company issued an aggregate of 136,527 shares of common stock to the holder of convertible note for payment of interest for the three months ending March 31, 2026. The fair value of these shares was $7,000.

 

On April 30, 2026, the Company issued an aggregate of 466,800 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $2,833.

 

On May 1, 2026, the Company issued an aggregate of 1,562,500 shares of common stock to an employee as a signing bonus. The fair value of these shares was $10,000.

 

On May 31, 2026, the Company issued an aggregate of 451,245 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $2,833.

 

On June 10, 2026, the Company issued an aggregate of 250,000 shares of common stock to Robert Carmichael for compensation for board of directors’ fees for December 2025. The fair value of these shares was $1,500.

 

On June 10, 2026, the Company issued an aggregate of 250,000 shares of common stock to Chrles F. Hyatt for compensation for board of directors’ fees for December 2025. The fair value of these shares was $1,500.

 

On June 10, 2026, the Company issued an aggregate of 1,097,561 shares of common stock to Robert Carmichael for compensation for board of directors’ fees for the first quarter ended March 31, 2026. The fair value of these shares was $4,500.

 

On June 10, 2026, the Company issued an aggregate of 1,097,561 shares of common stock to Charles F. Hyatt for compensation for board of directors’ fees for the quarter ended March 31, 2026. The fair value of these shares was $4,500.

 

On June 30, 2026, the Company issued an aggregate of 1,022,727 shares of common stock to Charles F. Hyatt for compensation for board of directors’ fees for quarter June 30, 2026. The fair value of these shares was $4,500.

 

On June 30, 2026, the Company issued an aggregate of 1,097,561 shares of common stock to Robert Carmichael for compensation for board of directors’ fees for quarter ended March 31, 2026. The fair value of these shares was $4,500.

 

On June 30, 2026, the Company issued an aggregate of 515,857 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was $2,833.

 

On June 30, 2026, the Company issued an aggregate of 136,527 shares of common stock to the holder of a convertible note for payment of interest for the three months ended June 30, 2026. The fair value of these shares was $7,000.

 

On July 1, 2026, in connection with the Sunrise Paddleboards asset acquisition, the Company issued 42,000,000 shares of common stock to the sole member and owner of Sunrise Paddleboards and 1,000,000 shares of common stock to an employee of Sunrise Paddleboards. The fair value of these shares was $189,200.

 

18
 

 

On July 31, 2026, the Company issued an aggregate of 635,101 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was approximately $2,833.

 

On August 31, 2026, the Company issued an aggregate of 711,577 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was approximately $2,833.

 

On September 30, 2026, the Company issued an aggregate of 870,664 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary. The fair value of these shares was approximately $2,833.

 

On September 30, 2026, the Company issued an aggregate of 1,125,000 shares of common stock to Robert Carmichael, 1,125,000 shares to Charles F. Hyatt and 1,125,000 shares to Mikkel Pitzner as compensation for board of directors’ fees for the quarter ended September 30, 2026. The fair value of each issuance was $4,500.

 

On September 30, 2026, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ended September 30, 2026. The fair value of these shares was $7,000.

 

Preferred Stock

 

During the second quarter of 2010, the holders of the majority of the Company’s outstanding shares of common stock approved an amendment to the Company’s Articles of Incorporation authorizing the issuance of 10,000,000 shares of blank check preferred stock. The blank check preferred stock as authorized has such voting powers, designations, preferences, limitations, restrictions and relative rights as may be determined by the Board of Directors of the Company from time to time in accordance with the provisions of the Florida Business Corporation Act. In April 2011, the Board of Directors designated 425,000 shares as Series A Convertible Preferred Stock. Each share of Series A Convertible Preferred Stock is convertible into a share of the Company’s common stock at any time at the option of the holder at a conversion price of $18.23 per share. Holders of shares of Series A Convertible Preferred Stock are entitled to 250 votes for each share held. The Company’s common stock and Series A Convertible Preferred Stock vote together on any matters submitted to our shareholders. As of September 30, 2026, and December 31, 2025, 425,000 shares of Series A Convertible Preferred Stock are issued and outstanding and are owned by Robert Carmichael.

 

Equity Incentive Plan

 

On May 26, 2021 the Company adopted an Equity Incentive Plan (the “Plan”). Under the Plan, stock options may be granted to employees, directors, and consultants in the form of incentive stock options or non-qualified stock options, stock purchase rights, time vested and/performance invested restricted stock, and stock appreciation rights and unrestricted shares may also be granted under the Plan. 25,000,000 shares are reserved for issuance under the Plan. The term of the Plan is ten years.

 

The Company also issued options outside of the Plan that were not approved by the security holders. These options may be granted to employees, directors, and consultants in the form of incentive stock options or non-qualified stock options.

 

Equity Compensation Plan Information as of September 30, 2026:

 

  

Number of

securities

to be issued upon
exercise of
outstanding options,
warrants and rights
(a)

  

Weighted –

average
exercise price of

outstanding options,
warrants and rights
(b)

  

Number of

securities
remaining available

for future issuances

under equity
compensation plans
(excluding securities

reflected in column
(a)

 
Equity Compensation Plans Approved by Security Holders   -    -    24,830,882 
Equity Compensation Plans Not Approved by Security Holders   -    -    — 
Total   -    -    24,830,882 

 

19
 

 

Options

 

As of September 30, 2026, the Company had no stock options outstanding. For the nine months ended September 30, 2026, and the year ended December 31, 2025, the Company issued no options to purchase shares.

 

For the three and nine months ended September 30, 2026, the Company recognized $0 of non-cash stock compensation expense related to options. As of September 30, 2026, the Company had no unrecognized pre-tax non-cash compensation expense related to outstanding stock options.

 

The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances. The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following:

 

 

    Nine Months ended September 30,  
    2026     2025  
Expected volatility   172.0% - 346.4 %   172.0 – 346.4 %
Expected term     .5 –4. Years       1.5 – 5.0 Years  
Risk-free interest rate     0.16% - 4.64 %     0.16% - 4.64 %
Forfeiture rate     0.17 %     0.17 %

 

The expected volatility was determined with reference to the historical volatility of the Company’s common stock. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury rate in effect at the time of grant.

 

A summary of the status of the Company’s outstanding stock options as of September 30, 2026 and December 31, 2025 and changes during the periods ending on such dates is as follows:

 

   Number of  

Weighted

Average

Exercise

  

Weighted

Average

Remaining

Contractual

  

Aggregate

Intrinsic

 
   Options   Price   Life in Years   Value 
Outstanding at December 31, 2025   238,439,167   $0.0362    1.43    - 
Granted   -    -    -    - 
Forfeited   (170,999,530)   0.0379    -    - 
Exercised   -    -    -    - 
Cancelled   -    -    -    - 
Outstanding – December 31, 2025   67,439,637   $0.0360    1.43    - 
Exercisable – December 31, 2025   41,057,753   $0.0211    1.33   $0 
                     
Granted   -    -    -    - 
Forfeited   (1,475,000)   0.0379    -    - 
Exercised   -    -    -    - 
Expired   (35,295,237)   -    -    - 
Cancelled   -    -    -    - 
Outstanding – June 30, 2026   29,219,400   $0.043268    1.07    - 
Expired – September 30, 2026   (29,219,400)  $-    -   $- 
Outstanding – September 30, 2026   0    -    0    0 
Exercisable – September 30, 2026   0    -    0    0 

 

At September 30, 2026, there were no outstanding stock options and no related unrecognized stock option expense.

 

20
 

 

Warrants

 

On January 18, 2023 and February 18, 2023, the Company issued to Charles Hyatt, an aggregate of 11,428,570 units, with each unit consisting of one share of common stock and a two-year common stock purchase warrant to purchase one share of common stock at an exercise price of $0.0175 per share in consideration of $200,000.

 

A summary of the Company’s warrants as of December 31, 2025 and changes during the nine months ended September 30, 2026 is presented below:

 

 

   Number of  

Weighted

Average

Exercise

  

Weighted

Average

Remaining

Contractual

  

Aggregate

Intrinsic

 
   Warrants   Price   Life in Years   Value 
Outstanding – December 31, 2025   25,684,521   $0.0247    0.93   $24,000 
Granted   -    -    -    - 
Exercised   -                
Forfeited or Expired   25,684,521    0.0247    0.93    24,000 
Outstanding – September 30, 2026   0   $0    0    0 
Exercisable – September 30, 2026   0   $0    0   $0 

 

Note 8. Commitments and contingencies

 

Royalty Agreement

 

On April 6, 2018, the Company entered into a Patent License Agreement with Setaysha Technical Solutions, LLC (“STS”). The agreement required the Company to pay earned royalties based on sales of licensed products and established a minimum annual royalty obligation. On June 30, 2020, the Company entered into Addendum No. 2 to the Patent License Agreement. Addendum No. 2 established certain limitations and expectations regarding assistance to be provided by STS in connection with the design and commercialization of certain diving products and revised the minimum royalty provisions as consideration for previously uncompensated development services. Under Addendum No. 2, the Company is required to pay STS a minimum annual royalty that commenced at $60,000, payable in quarterly installments of $15,000, beginning in December 2019 and increasing by 2.15% annually. The minimum annual royalty was temporarily increased by an additional $60,000 for fiscal years 2022, 2023 and 2024. In the fourth quarter of each calendar year, the minimum royalties paid for the year are reconciled against earned royalties, with any overpayment of minimum royalties credited against the fourth-quarter earned royalties otherwise due.

 

On January 24, 2024, the Company entered into Addendum No. 3, which would have deferred the additional $60,000 minimum royalty applicable to fiscal 2024 until fiscal 2025. On February 7, 2025, the Company entered into Addendum No. 4, which voided the provisions and actions of Addendum No. 3 and restored the minimum royalty schedule established by Addendum No. 2. Addendum No. 4 states that earned royalties for fiscal 2024 met or exceeded the total 2024 minimum royalty requirement of $126,750. Accordingly, the additional $60,000 minimum royalty obligation concluded in fiscal 2024, and no additional minimum royalty is required for fiscal 2025 or fiscal 2026. The inflation-adjusted base minimum royalties for fiscal 2025 and fiscal 2026 are $68,188 and $69,654, respectively.

 

Addendum No. 2 also provided that, if the Company terminated the Patent License Agreement before December 31, 2024, the Company would have been required to pay STS $180,000, reduced by cumulative royalties paid for the years 2019 through 2024 in excess of $334,961. Because the Company did not terminate the agreement before December 31, 2024, this contingent termination-payment provision has expired.

 

The original Patent License Agreement required the Company to issue shares of its common stock having a fair value of $30,000 to STS as an initial license fee. On November 1, 2022, the Company issued 1,155,881 shares of common stock having a fair value of $30,000. The Company recorded royalty expense under the agreement of $125,159 and $91,907 for the years ended December 31, 2024 and 2025, respectively. Accrued royalties under the agreement, included in other liabilities on the Company’s consolidated balance sheets, were $48,726 at September 30, 2026 and $21,678 at December 31, 2025.

 

21
 

 

Consulting and Employment Agreements

 

On August 1, 2021, the Company and Blake Carmichael entered into a three-year employment agreement (the “Blake Carmichael Employment Agreement”) pursuant to which Mr. Carmichael served as Chief Executive Officer of BLU3. In consideration for his services, Blake Carmichael received (i) an annual base salary of $120,000, payable in accordance with the customary payroll practices of the Company, (ii) a cash bonus equal to 5% of the net income of BLU3, payable quarterly, beginning with the first full calendar quarter after the execution of the agreement, and (iii) upon execution of the Carmichael Employment Agreement, a non-qualified five-year stock option to purchase 3,759,400 shares at $0.0399, 33.3% of which shares vest immediately, 33.3% vest on the second anniversary, and 33.3% vest on the third anniversary of the agreement. In addition, Blake Carmichael is entitled to receive a five-year stock option to purchase up to 18,000,000 shares of common stock at an exercise price of $0.0399 per share that will vest upon annual financial metrics based upon a revenue measurement, expediency measurement and an EBITDA measurement. A measurement was made for the nine months ended September 30, 2026 resulting in no additional expense since the vesting criteria were not met.

 

On September 3, 2021, SSI and Christeen Buban entered into a three-year employment agreement (the “Buban Employment Agreement”) pursuant to which Ms. Buban shall serve as the President of SSI. In consideration for her services, Mrs. Buban shall receive (i) an annual base salary of $110,000, payable in accordance with the customary payroll practices of the Company, (ii) a car allowance and cell phone allowance of $10,800 per year, (iii) a five-year option issued under the Plan to purchase 300,000 shares of common stock of the Company at $0.0531 per share, which option vests quarterly over the eight calendar quarters.

 

In addition, Mrs. Buban is entitled to receive a five-year stock option to purchase up to 7,110,000 shares of common stock of the Company at an exercise price of $0.0531 per share, which vests upon the attainment of certain defined annual financial metrics, as set forth in the Buban Employment Agreement. A measurement was made for the nine months ended September 30, 2026 and no expense was recorded based upon the vesting criteria not being met.

 

On January 17, 2022, the Company entered into an agreement with The Crone Law Group, PC (“CLG”) for the provision of legal services. In consideration therefore, the Company will pay CLG a monthly flat fee of $3,000 for SEC reporting work and its normal hourly rate for other legal work and issued 1,000,000 shares of common stock with a fair market value of $27,500 to CLG.

 

On May 2, 2022, the Company entered into a two-year employment agreement with Steven Gagas (the “Gagas Employment Agreement”) pursuant to which Mr. Gagas shall serve as the General Manager of the dive shop currently operating within LBI. In consideration for his services Mr. Gagas shall receive an annual salary of $50,000.

 

On May 2, 2022, LBI, entered into a lease assignment agreement with Gold Coast Scuba, LLC and Vicnsons Realty Group, LLC whereby LBI is the assignee of a three year lease for the property located at 259 Commercial Blvd., Suites 2 and 3 in Lauderdale-By-The Sea, Florida for $2,816 per month base rent. The lease expired on March 31, 2023 and LBI is currently renting on a month to month basis. LBI has the option to renew the lease for a two year term with an increase of base rent of 3.5%.

 

On September 14, 2022, SSI entered into a sixty-month lease renewal for its facility in Huntington Beach, California commencing on February 1, 2022 with base rent of approximately $17,550 per month for the first 24 months with an annual escalation clause of 3.0% thereafter. Obligations under the lease are guaranteed by the Company. The Company paid an additional security deposit of $10,727 upon entering into the lease.

 

On September 30, 2022, SSI entered into a sublease of its facility in Huntington Beach, California with Camburg Engineering, Inc. (“Tenant”) commencing October 1, 2022, The term of the sublease is through December 31, 2023, with a base monthly rent of $2,247 for the first twelve months with a 3% annual escalation thereafter. The Tenant also pays a monthly common area maintenance of $112. The Tenant provided a security deposit of $2,426 upon entering into the sublease.

 

On December 22, 2022, the U.S. Consumer Products Safety Commission (the “CPSC”) issued a voluntary recall notice for the Nomad tankless dive system, which is distributed by BLU3, Inc. As part of the recall procedure, the CPSC has approved the Company’s proposed remedy for the recall and BLU3 received units back from consumers to repair affected Nomad units. The Company has evaluated the costs of this recall and has deemed it necessary to set an allowance of $160,500 for such costs. During the twelve months ended December 31, 2023 the Company repaired and returned 653 units to customers resulting in a reduction of the allowance of $93,161 for the twelve months ended December 31, 2023.

 

Legal

 

There were no outstanding legal issues as of September 30, 2026.

 

Note 9. Subsequent Events

 

Except as set forth below, management evaluated subsequent events occurring after September 30, 2026 through the date the financial statements were issued and determined that there were no subsequent events requiring adjustment to or disclosure in the consolidated financial statements.

 

Blake Carmichael, the chief executive officer and president of BLU3, was appointed President and Chief Operating Officer of the Company, effective as of November 4, 2026. Upon Blake Carmichael’s appointment, Robert Carmichael resigned as President of the Company.

 

22
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and related notes appearing in this Quarterly Report. Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. Forward-looking statements represent our management’s beliefs and assumptions only as of the date of this Quarterly Report. Actual future results may be materially different from what we expect. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they are made, except as required by applicable law.

 

The management’s discussion and analysis of our financial condition and results of operations are based upon our unaudited financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

Overview

 

The Company owns and operates a portfolio of companies with a concentration in the industrial and recreational diving industry. The Company, through its subsidiaries, designs, tests, manufactures, and distributes recreational hookah diving, yacht-based scuba air compressors and nitrox generation systems and scuba and water safety products in the United States and internationally.

 

The Company has five subsidiaries focused on various sub-sectors:

 

  ● Brownie’s Third Lung - Surface Supplied Air (“SSA”)
  ● BLU3, Inc. - Ultra-Portable Tankless Dive Systems
  ● LW Americas - High Pressure Gas Systems
  ● Submersible Systems, Inc. - Redundant Air Tank Systems
  ● Live Blue, Inc. – Guided Tours and Retail

 

Our wholly owned subsidiaries do business under their respective trade names on both a wholesale and retail basis from our headquarters and manufacturing facility in Pompano Beach, Florida, a manufacturing facility in Huntington Beach, California, and a retail facility in Fort Lauderdale, Florida.

 

The Company, through its wholly owned subsidiaries, designs, tests, and manufactures tankless dive systems, rescue air systems and yacht-based self- contained underwater breathing apparatus (“SCUBA”) air compressor and nitrox generation fill systems. In addition, the Company is the exclusive distributor for North and South America for Lenhardt & Wagner GmbH (“L&W”) compressors in the high-pressure breathing air and industrial gas markets. The Company is also building a guided tour operation that includes dive retail. Lastly, The Company is the exclusive United States and Caribbean distributor for Chrysalis Trading CC, a South African manufacturer of fitness and dive equipment, doing business as Bright Weights (“Bright Weights”), of a dive ballast system produced in South Africa.

 

Results of Operations

 

Net Revenues, Costs of Net Revenues and Gross Profit

 

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

 

Net revenues increased 27.6% for the three months ended September 30, 2026 compared with the three months ended September 30, 2025. The increase in net revenues was broad-based, with higher revenues at BTL, BLU3, SSI and LWA, and reflects higher advertising and marketing expenditures, particularly online and social media advertising, which supported increased sales activity during the three months ended September 30, 2026. LBI also contributed revenue during the three months ended September 30, 2026 following the acquisition of Sunrise Paddleboards LLC (“Sunrise Paddleboards”) on July 1, 2026.

 

For the three months ended September 30, 2026, cost of net revenues was 48.4% of revenues compared with 53.6% for the three months ended September 30, 2025. The decrease in cost of net revenues as a percentage of revenues reflects revenue growth that outpaced the increase in production costs during the period. Related-party royalty expense increased 32.0% for the three months ended September 30, 2026 compared with the corresponding period in 2025. The increase in related-party royalty expense was primarily attributable to higher sales subject to the Company’s existing royalty arrangements.

 

Gross profit margin was 51.6% for the three months ended September 30, 2026 compared with 46.4% for the three months ended September 30, 2025. The increase in gross profit margin was primarily attributable to revenue growth outpacing the increase in cost of net revenues, resulting in cost of net revenues decreasing to 48.4% of revenues from 53.6% in the corresponding period in 2025.

 

23
 

 

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025

 

Net revenues increased 16.6% for the nine months ended September 30, 2026 compared with the nine months ended September 30, 2025. The increase in net revenues was primarily attributable to higher revenues at BTL, BLU3 and SSI, with LWA’s revenues also modestly higher for nine months ended September 30, 2026. The increase at BTL reflects improved dealer terms and product modifications, the increase at BLU3 reflects an improved product mix and increased online and social media marketing, and the increase at SSI reflects sales to a broader customer base and continued demand for its product lines. LBI also contributed revenue during the third quarter of 2026 following the acquisition of Sunrise Paddleboards.

 

For the nine months ended September 30, 2026, cost of net revenues was 50.0% of revenues compared with 61.6% for the nine months ended September 30, 2025. Related-party royalty expense increased 47.3% for the nine months ended September 30, 2026 compared with the nine months ended September 30, 2025. The decrease in cost of net revenues as a percentage of revenues was primarily attributable to increased sales combined with lower material costs relative to revenues and improved purchasing practices. The increase in related-party royalty expense was primarily attributable to higher sales subject to the Company’s existing royalty arrangements.

 

Gross profit margin was 50.0% for the nine months ended September 30, 2026 compared with 38.4% for the nine months ended September 30, 2025. The increase in gross profit margin was primarily attributable to increased revenues and a reduction in cost of net revenues as a percentage of revenues, including lower material costs relative to sales and improved purchasing practices.

 

Operating Expenses

 

Operating expenses consist of selling, general and administrative (“SG&A”) expenses and research and development costs and are reported on a consolidated basis for our operating segments. Total operating expenses increased 27.0% and 53.6% for the three and nine months ended September 30, 2026, respectively, compared with the corresponding periods in 2025. R&D expenses increased 5,198.4% and 719.1% for the three and nine months ended September 30, 2026, respectively, compared with the corresponding periods in 2025.

 

Selling, General & Administrative Expenses

 

SG&A increased 25.1% and 52.7% for the three and nine months ended September 30, 2026, respectively, compared with the corresponding periods in 2025. The increase in SG&A expense was primarily attributable to higher payroll, professional fees and advertising expense. For the nine-month period, the increase also reflects higher rent and occupancy costs and other operating expenses. SG&A expenses were comprised of the following:

 

Expense Item  Three Months Ended September 30, 2026   Three Months Ended September 30, 2025   % Change   Nine Months Ended September 30, 2026   Nine Months Ended September 30, 2025   % Change 
Payroll, Selling & Administrative  $358,493   $292,950    22.4%  $934,549   $843,888    10.7%
Stock Compensation Expense   16,500    9,000    83.3%   34,500    27,000    27.8%
Professional Fees   56,268    (18,417)   405.5%   361,300    211,196    71.1%
Advertising   137,890    72,859    89.3%   355,361    257,841    37.8%
All Other   467,396    472,199    (1.0)%   1,568,312    790,782    98.3%
Total SG&A  $1,036,547   $828,591    25.1%  $3,254,022   $2,130,707    52.7%

 

Payroll, selling and administrative expense increased 22.4% and 10.7% for the three and nine months ended September 30, 2026, respectively, compared with the corresponding periods in 2025. The increase in payroll expense reflects additional personnel hired during 2026 and higher staffing costs associated with increased operating activity.

 

Non-cash stock compensation expense increased 83.3% and 27.8% for the three and nine months ended September 30, 2026, respectively, compared with the corresponding periods in 2025. The increase in non-cash stock compensation expense reflects additional equity compensation recognized for directors and employees during 2026.

 

Professional fees increased 405.5% and 71.1% for the three and nine months ended September 30, 2026 compared with the corresponding periods in 2025. The increase in professional fees was primarily attributable to higher audit, legal, consulting and other professional fees. The three-month increase was also affected by a net credit to professional fees recorded in the three months ended September 30, 2025.

 

24
 

 

Advertising expense increased 89.3% and 37.8% for the three and nine months ended September 30, 2026, respectively, compared with the corresponding periods in 2025. The increase in advertising expense was primarily attributable to increased online and social media advertising, particularly for BLU3, together with increased marketing activity across the Company.

 

All other SG&A expenses decreased 1.0% for the three months ended September 30, 2026 and increased 98.3% for the nine months ended September 30, 2026, compared with the corresponding periods in 2025. All other SG&A expenses were substantially unchanged for the three-month period as increases in rent and occupancy and other operating costs were offset by decreases in other miscellaneous expenses. For the nine-month period, the increase was primarily attributable to higher rent and occupancy costs, insurance, payroll-related taxes and benefits, and other operating expenses. Rent expense during the three months ended September 30, 2026 also reflects costs associated with the Company’s new Davie facility beginning in August 2026.

 

Research & Development Expenses (R&D Expenses)

 

R&D expenses for the three and nine months ended September 30, 2026 increased 5,198.4% and 719.1%, respectively, compared with the corresponding periods in 2025. The increase in research and development expense was primarily attributable to a more deliberate allocation of engineering labor and other development costs to research and development activities. The increase was primarily related to engineering labor at LWA associated with the redesign of certain systems and related technical re-certification efforts, as well as other product development activities across the Company.

 

Other Income/Expense

 

For the three and nine months ended September 30, 2026, other income was $377,576 and $1,228,604, respectively, compared with $114,315 for each of the corresponding periods in 2025. Interest expense was $28,606 and $146,228 for the three and nine months ended September 30, 2026, respectively, compared with $55,587 and $53,804 for the corresponding periods in 2025. The increase in other income was primarily attributable to the Internal Revenue Service’s Employee Retention Credit related income, the write-off and settlement of certain historical liabilities, prior-period accounting corrections and other adjustments identified through the Company’s ongoing reconciliation and financial reporting processes, as well as other refunds and non-operating items. Other income during the third quarter also included gains associated with the disposition of certain assets and additional adjustments resulting from the reconciliation of historical account balances. Several of these items are non-recurring and we believe are not indicative of the Company’s ongoing operating performance.

 

Liquidity and Capital Resources

 

We had cash of $790,026 as of September 30, 2026. The following table summarizes total current assets, total current liabilities and working capital at September 30, 2026, as compared to December 31, 2025.

 

   September 30, 2026   December 31, 2025   % change 
   (unaudited)         
Total current assets  $4,552,209   $3,040,113    49.7%
Total current liabilities  $2,690,775   $2,461,040    9.3%
Working capital  $1,861,433   $579,073    221.5%

 

Total current assets increased to $4,552,209 at September 30, 2026 from $3,040,113 at December 31, 2025, while total current liabilities increased to $2,690,775 from $2,461,040. Working capital increased to $1,861,433 from $579,073. The increase in current assets was primarily attributable to increases in cash, inventory, accounts receivable, and prepaid expenses and other current assets. The increase in current liabilities was primarily attributable to higher accounts payable and accrued liabilities and operating lease liabilities, partially offset by reductions in current debt balances. As a result, working capital increased significantly from December 31, 2025.

 

Summary Cash Flows

 

   Nine months ended September 30, 
   2026   2025 
   (unaudited) 
Net cash provided by operating activities  $711,316   $61,865 
Net cash used in investing activities  $29,022   $- 
Net cash used in financing activities  $200,153   $- 

 

25
 

 

Net cash provided by operating activities for the nine months ended September 30, 2026 was $711,316. Net cash provided by operating activities primarily reflects net income for the period, adjusted for non-cash items and changes in operating assets and liabilities. Cash generated from earnings and increases in accounts payable and accrued liabilities was partially offset by increased investment in inventory, higher accounts receivable and prepaid expenses, and cash payments associated with operating leases.

 

Net cash used in investing activities for the nine months ended September 30, 2026 was $29,022. Net cash used in investing activities was primarily attributable to purchases of property and equipment. The acquisition of Sunrise Paddleboards was principally a non-cash transaction and therefore did not materially affect investing cash flows during the period.

 

Net cash used in financing activities for the nine months ended September 30, 2026 was $200,153. Net cash used in financing activities was primarily attributable to repayments of loans and notes payable, including related-party debt, partially offset by proceeds from new equipment financing during the period.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis. Although the Company reported net income of $1,371,382 for the nine months ended September 30, 2026 and had a working capital surplus of approximately $1.9 million, the Company continues to have an accumulated deficit of approximately $16.9 million and a history of operating losses. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the consolidated financial statements are issued. Management’s plans to alleviate this substantial doubt include increasing revenues, controlling operating expenses, and obtaining additional capital as needed. However, there can be no assurance that these plans will be successful. Accordingly, substantial doubt about the Company’s ability to continue as a going concern remains. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Critical Accounting Policies

 

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the reported periods. The more critical accounting estimates include estimates related to revenue recognition, valuation of inventory, allowance for doubtful accounts, and equity-based transactions. We also have other key accounting policies, which involve the use of estimates, judgments and assumptions that are significant to understanding our results, which are described in Note 2 to our unaudited consolidated financial statements contained in this Quarterly Report.

 

Recent Accounting Pronouncements

 

There were various accounting standards and interpretations issued recently, none of which are expected to have a material effect on the Company’s operations, financial position or cash flows.

 

These recent accounting pronouncements are described in Note 2 to our unaudited consolidated financial statements contained in this Quarterly Report.

 

Off Balance Sheet Arrangements

 

We currently have no off-balance sheet arrangements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company is a smaller reporting company and is not required to provide this information.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain “disclosure controls and procedures” as such term is defined in Rule 13a-15(e) under Exchange Act. In designing and evaluating our disclosure controls and procedures, our management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of disclosure controls and procedures are met. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Based on their evaluations as of September 30, 2026, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were not effective such that the information relating to our company, required to be disclosed in our Securities and Exchange Commission reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) is accumulated and communicated to our management, including our Chief Executive Officer, to allow timely decisions regarding required disclosure as a result of continuing material weaknesses in our internal control over financial reporting described below. A material weakness is a deficiency, or combination of deficiencies, that results in more than a remote likelihood that a material misstatement of annual or interim financial statements will not be prevented or detected.

 

26
 

 

Our management, including our Principal Executive Officer and Principal Financial Officer, have evaluated the effectiveness of the design and operations of our disclosure controls and procedures (defined in Exchange Act Rules 13a-15(c) and 15d-15(e)) as of September 30, 2026 and based upon the such evaluation, have concluded that the disclosure controls and procedures were not effective as of such date due to the material weaknesses set forth below.

 

  ● Insufficient number and lack of qualified accounting department and administrative personnel and support;
     
  ● Insufficient written policies and procedures to ensure the correct application of accounting and financial reporting with respect to GAAP and SEC disclosure requirements;
     
  ● Insufficient segregation of duties, oversight of work performed and lack of controls in our finance and accounting functions due to limited personnel;
     
  ● Company’s systems that impact financial information and disclosures have ineffective information technology controls;
     
  ● Inadequate controls surrounding revenue recognition, to ensure that all material transactions and developments impacting the financial statements are reflected and properly recorded; and
     
  ● Evaluation of disclosure controls and procedures was not sufficiently comprehensive due to limited personnel.

 

Subject to sufficient resources, management expects to remediate the material weaknesses identified above as follows:

 

  ● Management has leveraged and will continue to leverage experienced consultants to assist with ongoing GAAP and SEC compliance requirements. We intend to expand our finance department through the hiring of a certified public accountant to strengthen the segregation of duties, internal controls and enhance our current staff.
     
  ● Segregation of duties is being analyzed and adjusted Company-wide, where possible. The Company intends to hire additional personnel in the accounting department, as well as the documentation of controls and procedures.
     
  ● The Company plans on evaluating various accounting systems to enhance its system controls.

 

We will continue to monitor and evaluate the effectiveness of our internal control over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow. We do not, however, expect that the material weaknesses in our disclosure controls will be remediate until such time as we have added to our accounting and administrative staff allowing improved internal control over financial reporting.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting that occurred during our last fiscal quarter that have materially affected or are reasonably likely to materially affect our internal control over financial reporting except as set forth below.

 

We believe that weaknesses in our financial reporting review and verification processes contributed to the errors requiring the restatement of our financial statements reported in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. Accordingly, management, under the oversight of our board of directors, has commenced additional remediation measures intended to strengthen our financial reporting and disclosure controls. These measures include:

 

  ● Enhancing management and Board-level review of quarterly and annual financial statements and SEC filings;
     
  ● Strengthening period-end close, reconciliation and verification procedures, including procedures specifically designed to confirm that financial information corresponds to the correct reporting period and fiscal year;
     
  ● Establishing additional review checkpoints intended to compare reported financial results with underlying accounting records and management’s understanding of actual operating performance;
     
  ● Implementing technology-assisted financial review procedures, including AI-enabled analytical testing, as a supplemental control designed to identify period inconsistencies, mathematical discrepancies, unusual variances, internal inconsistencies and other potential reporting anomalies for further human review;
     
  ● Requiring that exceptions or inconsistencies identified through these procedures be investigated and resolved prior to authorization of applicable SEC filings;
     
  ● Evaluating our accounting and financial-reporting organizational structure, including the qualifications, responsibilities and resources necessary to support our SEC reporting obligations; and
     
  ● Implementing personnel and responsibility changes within our financial reporting function designed to strengthen technical accounting capability, accountability, review and segregation of responsibilities and to address identified sources of the reporting errors.

 

The Company expects these remediation efforts to continue as management and the Board evaluate the Company’s financial reporting personnel, processes, systems and controls. There can be no assurance that the measures implemented to date will fully remediate the Company’s material weaknesses or prevent future misstatements, and the Company may implement additional measures as its evaluation continues.

 

27
 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

There are no pending legal proceedings to which we are a party or in which any director, officer or affiliate of ours, any owner of record or beneficially of more than 5% of any class of our voting securities, or security holder is a party adverse to us or has a material interest adverse to us.

 

ITEM 1A. RISK FACTORS

 

The Company is a smaller reporting company and is not required to provide this information.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

There were no sales of equity securities during the period covered by this Report that were not registered under the Securities Act and were not previously reported in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K filed by the Company, except as noted below.

 

On July 1, 2026, in connection with the Sunrise Paddleboards asset acquisition, the Company issued 42,000,000 shares of common stock to the sole member and owner of Sunrise Paddleboards and 1,000,000 shares of common stock to an employee of Sunrise Paddleboards.

 

On July 31, 2026, the Company issued an aggregate of 635,101 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary.

 

On August 31, 2026, the Company issued an aggregate of 711,577 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary.

 

On September 30, 2026, the Company issued an aggregate of 870,664 shares of common stock to Blake Carmichael as compensation for cash reduction in his salary.

 

On September 30, 2026, the Company issued an aggregate of 1,125,000 shares of common stock to Robert Carmichael for board of directors’ compensation for the quarter ended September 30, 2026.

 

On September 30, 2026, the Company issued an aggregate of 1,125,000 shares of common stock to Charles F. Hyatt for board of directors’ compensation for the quarter ended September 30, 2026.

 

On September 30, 2026, the Company issued an aggregate of 1,125,000 shares of common stock to Mikkel Pitzner for board of directors’ compensation for the quarter ended September 30, 2026.

 

On September 30, 2026, the Company issued an aggregate of 136,527 shares of common stock to the holders of convertible notes for payment of interest for the three months ended September 30, 2026.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURE

 

None.

 

ITEM 5. OTHER INFORMATION

 

Appointment of Blake Carmichael as President and Chief Operating Officer

 

Blake Carmichael, age 31, the chief executive officer and president of BLU3 since December 2017, was appointed President and Chief Operating Officer of the Company, effective as of November 4, 2026. Since December 2017, Mr. Carmichael has served as Chief Executive Officer of BLU3 where his primary focus was the development of battery powered hookah diving products. Mr. Carmichael graduated from Florida Atlantic University in May 2017 as an electrical engineer with a Bachelor of Science in Electrical Engineering.

 

28
 

 

Upon Blake Carmichael’s appointment, Robert Carmichael resigned as President but remains Chairman, Chief Executive Officer and a director of the Company.

 

The appointment of Blake Carmichael was not pursuant to any arrangement or understanding between him and any other person.

 

Blake Carmichael is the son of Robert Carmichael.

 

Blake Carmichael has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K, except as described elsewhere in this Quarterly Report, including in the footnotes to the financial statements and in Part II, Item 2 above.

 

The Company has not entered into any material plan, contract or arrangement with Blake Carmichael, and no grant or award has been made to Blake Carmichael in connection with his appointment as President and Chief Operating Officer except that he will be entitled to a $25,000 increase in his annual base salary to be paid in accordance with the regular payroll practices of the Company.

 

Rule 10b5-1 trading arrangements

 

During the quarter ended September 30, 2026, no director, officer or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements.

 

ITEM 6. EXHIBITS

 

Exhibit Number   Exhibit
31.1   Certification of the Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2   Certification of the Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32   Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)
101.INS   Inline XBRL INSTANCE DOCUMENT
101.SCH   Inline XBRL TAXONOMY EXTENSION SCHEMA
101.CAL   Inline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
101.DEF   Inline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
101.LAB   Inline XBRL TAXONOMY EXTENSION LABEL LINKBASE
101.PRE   Inline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

29
 

 

SIGNATURES

 

In accordance with the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: November 4, 2026 BROWNIE’S MARINE GROUP, INC.
     
  By: /s/ Robert M. Carmichael
    Robert M. Carmichael
    Chief Executive Officer
    (Principal Executive Officer)
     
  By: /s/ Robert M. Carmichael
    Robert M. Carmichael
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

30

 


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-31.1

EX-31.2

EX-32

XBRL SCHEMA FILE

XBRL CALCULATION FILE

XBRL DEFINITION FILE

XBRL LABEL FILE

XBRL PRESENTATION FILE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: R42.htm

IDEA: R43.htm

IDEA: R44.htm

IDEA: R45.htm

IDEA: R46.htm

IDEA: R47.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: form10-q_htm.xml